News

UZ Leuven prosa team celebrates 10 years of tailored care for children

18 November 2024

For ten years, the prosa team at UZ Leuven has been ready to relieve children's anxiety and pain, both before and during medical procedures. Their approach to fear and pain in our children's hospital is unique for Belgium.

Belgium has been waiting for 20 years for national recognition of its centres of expertise for rare diseases

7 November 2024

Belgian doctors, hospitals and patients are collectively sounding the alarm. With a new Flemish and federal government in the making, they are calling for the Rare Diseases Plan to be put high on the agenda again. Belgium is one of the few European countries that does not have national reference centres for rare diseases. “The patient bears the brunt of this."

Newest mini pacemakers suitable for more than 80 per cent of patients

18 October 2024

Leuven cardiologists have for the first time implanted a new type of mini pacemaker applicable for almost anyone who needs a pacemaker.

UZ Leuven and KU Leuven invest 14 million euros in new cell and gene therapy facility

8 October 2024

UZ Leuven and KU Leuven are establishing an innovative facility for the production of Advanced Therapy Medicinal Products (ATMPs) on the Gasthuisberg Campus. At this facility, they want to develop pioneering therapies themselves from the end of 2025 and produce personalised treatments for individual patients

Successful first edition of Belgian Transplantoux Games in Leuven

26 September 2024

On 21 and 22 September, Transplantoux organised the very first edition of the Belgian Transplantoux Games in Leuven. The sporting event brought together transplant and dialysis patients, donors and sympathisers under the ‘healthy living and excercising after a transplant’ motto. Some 400 sportsmen and women competed for medals in more than 10 disciplines.

Nursing support can improve quality of life for skin lymphoma patients

16 September 2024

An UZ Leuven study shows that patient-centred, nurse-centred consultation can greatly improve the quality of life of people with skin lymphomas. It also showed that, thanks to personalised follow-up, fewer readmissions were needed on average.

New EUHA position paper highlights the role of university hospitals in sustainable care

11 September 2024

This week the European University Hospital Alliance (EUHA) published its position paper 'Rethinking Healthcare Systems'. Among other things, the paper pushes forward three key action points to ensure the future of European healthcare. Discover them here.

New storage method for donor hearts surpasses traditional storage on ice

5 September 2024

A UZ Leuven study shows the benefits of machine perfusion for longer and safer storage of donor hearts pending transplantation.

New warehouse makes hospital pharmacy future-proof

8 August 2024

In June the UZ Leuven hospital pharmacy got a brand-new warehouse, which is high-tech and future-oriented, including a lot of robotics. In a few years's time it will be further expanded to include a central compounding pharmacy, which will play a major role within the regional Plexus hospital network.

Immunotherapy can prevent dangerous blood transfusion in foetus

8 August 2024

A new study shows that the drug nipocalimab is a good alternative for the not harmless blood transfusion in a rhesus pregnancy: the drug ensures that the mother's antibodies can no longer go to the foetus.

Prof. Paul Herijgers starts as CEO of UZ Leuven

5 August 2024

On Monday 5 August prof. dr. Paul Herijgers starts as the new CEO of UZ Leuven. What will be the focus for the coming years? And what motivates him to take on the job of manager of UZ Leuven?

Leuven study unravels underlying mechanism of intestinal fibrosis

24 July 2024

Despite advancements in treating chronic inflammation, existing anti-inflammatory medications cannot prevent the development of intestinal fibrosis. Researchers from UZ Leuven and KU Leuven now identified several mechanisms crucial for the development of intestinal fibrosis in a recent study. With this information, they hope to develop potential new treatments.